Molecular Biophysics Laboratory, Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, India.
Molecular Biophysics Laboratory, Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, India
J Gen Physiol. 2019 Apr 1;151(4):489-504. doi: 10.1085/jgp.201812272. Epub 2019 Jan 23.
Voltage-dependent anion channels (VDACs) are β-sheet-rich transmembrane β-barrels that are vital for metabolite transport across the mitochondrial membrane. Under cellular stress, human VDACs hetero-oligomerize and coaggregate with proteins that can form amyloidogenic and neurodegenerative deposits, implicating a role for VDACs in proteotoxicity. However, whether VDACs possess intrinsic interaction sites that can lead to protein aggregation is not known. Here, we couple a systematic thiol replacement strategy with far-UV circular dichroism spectropolarimetry and UV scattering spectroscopy to map aggregation-prone regions of human VDACs, using isoform 3 as our model VDAC. We show that the region comprising strands β7-β9 is highly aggregation prone. Further, we find that an α1-β7-β9 interaction (involving the hVDAC3 N-terminal α1 helix) can lower protein aggregation, whereas perturbations of this interaction promote VDAC aggregation. We also show that hVDAC3 aggregation proceeds via a partially unfolded structure. Our findings allow us to propose a plausible mechanism for the role of human VDACs in forming proteotoxic aggregates in the cell. The key target sites on VDACs-strands β7-β9-may be useful for developing VDAC aggregation inhibitors.
电压门控阴离子通道 (VDACs) 是富含 β 片层的跨线粒体膜的 β-桶状蛋白,对于代谢物跨膜运输至关重要。在细胞应激下,人类 VDACs 异源寡聚化并与可以形成淀粉样和神经退行性沉积物的蛋白质聚集,表明 VDACs 在蛋白毒性中起作用。然而,VDACs 是否具有导致蛋白质聚集的固有相互作用位点尚不清楚。在这里,我们使用 3 型作为我们的模型 VDAC,结合系统的巯基替换策略与远紫外圆二色性光谱偏振和紫外散射光谱,来绘制人类 VDACs 的聚集倾向区域。我们表明,包含β7-β9 链的区域高度聚集倾向。此外,我们发现 α1-β7-β9 相互作用(涉及 hVDAC3 N 端 α1 螺旋)可以降低蛋白质聚集,而破坏这种相互作用会促进 VDAC 聚集。我们还表明,hVDAC3 的聚集是通过部分展开的结构进行的。我们的发现使我们能够提出人类 VDACs 在细胞中形成蛋白毒性聚集体的作用的合理机制。VDACs 上的关键靶位(β7-β9 链)可能对开发 VDAC 聚集抑制剂有用。